Abstract
The relationship to survival after first recurrence of oestrogen receptor (ER), nodal status and TNM stage at diagnosis, and treatment for advanced disease was studied in 457 females whose primary breast cancer was diagnosed in 1975 to 1981. Receptor concentration was the most important predictor of post-recurrence survival, with some additional information conveyed by nodal status. ER predicted survival after recurrence independently of nodal status, clinical stage or mode of therapy. Response to endocrine therapy is only a facet of the generally favourable prognosis of ER positive patients, rather than the sole explanation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shek, L., Godolphin, W. & Spinelli, J. Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients. Br J Cancer 56, 825–829 (1987). https://doi.org/10.1038/bjc.1987.298
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.298
This article is cited by
-
Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data
Cancer Causes & Control (2014)
-
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up
Breast Cancer Research and Treatment (2008)
-
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
Breast Cancer Research (2006)
-
Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy
Breast Cancer Research and Treatment (1995)